Live from the NIH registry
Studies recruiting near Asheville right now
Top 25 of 123 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Physiologic Signals and Signatures With the Accuryn Monitoring System - The Accuryn Registry
Intraabdominal Hypertension, Abdominal Compartment Syndrome
N/A
Observational 2,500 participants sought
Mission Health Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Potrero Medical
ERP to Improve Functioning in Veterans With OCD
Obsessive Compulsive Disorder (OCD), Comorbid Post-Traumatic Stress Disorder and OCD
N/A
Interventional 160 participants sought
Asheville VA Medical Center, Asheville, NC — Asheville, North Carolina (2.1 mi)
· Sponsor: VA Office of Research and Development
His-Bundle Corrective Pacing in Heart Failure
Right Bundle-Branch Block, Heart Failure
N/A
Interventional 120 participants sought
Mission Health — Asheville, North Carolina (2.1 mi)
· Sponsor: University of Rochester
Alleviant ALLAY-HFrEF Study
Heart Failure
N/A
Interventional 350 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Alleviant Medical, Inc.
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Parkinson Disease
Phase 2
Interventional 150 participants sought
Asheville Neurology Specialists, P.A. (Site #229) — Asheville, North Carolina (2.1 mi)
· Sponsor: Appello Pharmaceuticals, Inc.
mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma
Advanced Esophageal Adenocarcinoma, Advanced Gastric Adenocarcinoma
Phase 3
Interventional 382 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Cardiology Associates_Asheville — Asheville, North Carolina (2.1 mi)
· Sponsor: Novo Nordisk A/S
The Treatment of Painful Diabetic Neuropathy With Diet
Painful Diabetic Neuropathy (PDN), Peripheral Neuropathy With Type 2 Diabetes
N/A
Interventional 40 participants sought
AdventHealth Hendersonville — Hendersonville, North Carolina (18.2 mi)
· Sponsor: AdventHealth
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: SWOG Cancer Research Network
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
Margaret R Pardee Memorial Hospital — Hendersonville, North Carolina (18.2 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Anaplastic Kidney Wilms Tumor, Recurrent Kidney Wilms Tumor
Phase 2
Interventional 256 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Children's Oncology Group
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
Messino Cancer Centers — Asheville, North Carolina (2.1 mi)
· Sponsor: Eli Lilly and Company
Continuous Glucose Monitoring, Diabetes Education, and Peer Support for Management of Uncontrolled Type 2 Diabetes
Type 2 Diabetes Mellitus - Poor Control
N/A
Observational 100 participants sought
Whole Endo — Asheville, North Carolina (2.1 mi)
· Sponsor: Whole Endo
The Fourth Left Atrial Appendage Occlusion Study
Atrial Fibrillation, Stroke, Ischemic
N/A
Interventional 4,000 participants sought
Mission Hospital HCA — Asheville, North Carolina (2.1 mi)
· Sponsor: Hamilton Health Sciences Corporation
A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).
Diabetic Macular Edema (DME)
Phase 3
Interventional 514 participants sought
Asheville Eye Associates - Retina Division — Asheville, North Carolina (2.1 mi)
· Sponsor: 4D Molecular Therapeutics
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Stage I Breast Cancer
Phase 3
Interventional 1,670 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: NRG Oncology
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
Asheville Cardiology Associates Research Department — Asheville, North Carolina (2.1 mi)
· Sponsor: Duke University
Registry of Older Patients With Cancer
Chronic Myeloproliferative Disorders, Cognitive/Functional Effects
N/A
Observational 3,000 participants sought
Pardee Cancer Center — Hendersonville, North Carolina (18.2 mi)
· Sponsor: UNC Lineberger Comprehensive Cancer Center
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Lumbar Spinal Stenosis
N/A
Observational 8,000 participants sought
Mission Hospital — Asheville, North Carolina (2.1 mi)
· Sponsor: Stryker Instruments
Pimavanserin vs. Quetiapine for Treatment of Parkinson's Psychosis
Parkinson's Disease Psychosis
Phase 4
Interventional 358 participants sought
Asheville VA Medical Center, Asheville, NC — Asheville, North Carolina (2.1 mi)
· Sponsor: VA Office of Research and Development
A Study to Assess How Well and Safely Elafibranor Works in Adult Participants With Primary Sclerosing Cholangitis
Primary Sclerosing Cholangitis
Phase 3
Interventional 350 participants sought
Digestive Health Partners, PA — Asheville, North Carolina (2.1 mi)
· Sponsor: Ipsen